Membranous nephropathy in a patient with COVID-19 infection
Authors:
Open Access
- 7 October 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 35 (1) , 351-355
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccineKidney International, 2021
- Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccinationKidney International, 2021
- Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and ProteinuriaAmerican Journal of Kidney Diseases, 2021
- Membranous nephropathy in a patient with coronavirus disease 2019 (COVID-19): A case reportClinical Nephrology – Case Studies, 2021
- Kidney Biopsy Findings in Patients with COVID-19Journal of the American Society of Nephrology, 2020
- Visualization of putative coronavirus in kidneyKidney International, 2020
- How COVID-19 Has Changed the Management of Glomerular DiseasesClinical Journal of the American Society of Nephrology, 2020
- Renal Phospholipase A2 Receptor in Hepatitis B Virus-Associated Membranous NephropathyAmerican Journal of Nephrology, 2015
- Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsiesLaboratory Investigation, 2013
- The role of mast cell-derived secreted phospholipases A2 in respiratory allergyBiochimie, 2010